Compare HALO & CART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | CART |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.5B |
| IPO Year | 2001 | 2023 |
| Metric | HALO | CART |
|---|---|---|
| Price | $125.99 | $51.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 33 |
| Target Price | ★ $108.78 | $57.90 |
| AVG Volume (30 Days) | 2.2M | ★ 2.9M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.27 |
| EPS | ★ 3.11 | 1.02 |
| Revenue | $151,862,000.00 | ★ $3,742,000,000.00 |
| Revenue This Year | $34.69 | $13.77 |
| Revenue Next Year | $11.65 | $10.56 |
| P/E Ratio | ★ $39.88 | $50.62 |
| Revenue Growth | N/A | ★ 10.78 |
| 52 Week Low | $61.23 | $32.73 |
| 52 Week High | $125.43 | $52.68 |
| Indicator | HALO | CART |
|---|---|---|
| Relative Strength Index (RSI) | 74.21 | 64.38 |
| Support Level | $105.27 | $42.13 |
| Resistance Level | N/A | $51.93 |
| Average True Range (ATR) | 3.51 | 1.49 |
| MACD | 1.11 | 0.52 |
| Stochastic Oscillator | 99.04 | 92.14 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Maplebear (Instacart) is a grocery-focused delivery marketplace that connects national and regional grocers with consumers and couriers, and consumers with their favorite stores. Its app provides on-demand convenience for consumers, lets couriers earn income, and helps grocers scale through digital channels. The marketplace gathers valuable consumer behavior data, attracting consumer-packaged-goods advertisers that seek to reach consumers at the point of purchase. With approximately 600,000 shoppers and 2,200 retail partners, Instacart delivers to about 98% of households in the United States and Canada.